Pharmacogenomics Archives - Insights

How Pharmacogenomics Deliver More Precise Cancer Therapy

Mayo Clinic Laboratories — Thu, 11 Jun 2026 13:00:00 +0000

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss updates on the Protecting Access to Medicare Act (PAMA) and other policy changes affecting clinical diagnostics. Later, Dr. Pritt welcomes Ann Moyer, M.D., Ph.D., a molecular genetic pathologist at Mayo Clinic and chair of the hereditary genetics practice, to explore how precision therapeutics are improving cancer treatments.

The post How Pharmacogenomics Deliver More Precise Cancer Therapy appeared first on Insights.

Four ways diagnostics are driving more personalized care

William Morice, II, M.D., Ph.D. — Wed, 25 Mar 2026 13:00:00 +0000

Diagnostics power personalized care by guiding therapy selection, informing adjustments, and fueling the advancement of precision medicine.

The post Four ways diagnostics are driving more personalized care appeared first on Insights.

Cultivating a comprehensive test menu for organ transplant patients

Chris Bahnsen — Fri, 30 Jan 2026 14:00:00 +0000

Viral and pharmacogenomic testing help clinicians detect infection early, tailor immunosuppression, and improve long-term outcomes for organ transplant recipients.

The post Cultivating a comprehensive test menu for organ transplant patients appeared first on Insights.

Pharmacogenomics: Why is everyone talking about DPYD?

MCL Education — Thu, 16 Oct 2025 10:00:00 +0000

The rapidly evolving field of pharmacogenomics, the DPYD gene and its significance in oncology.

The post Pharmacogenomics: Why is everyone talking about DPYD? appeared first on Insights.

Advancing Immunosuppressive Therapy in Solid Organ Transplantation: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Precision Medicine

MCL Education — Fri, 06 Jun 2025 10:00:00 +0000

PACE/State of FL - The critical role of pharmacogenomics and therapeutic drug monitoring (TDM) in managing immunosuppressive therapy for solid organ transplant recipients.

The post Advancing Immunosuppressive Therapy in Solid Organ Transplantation: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Precision Medicine appeared first on Insights.

Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP

Barbara J. Toman — Tue, 08 Apr 2025 13:00:00 +0000

Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after non-liver organ transplants. Optimal tacrolimus levels are one of the important factors in survival of the transplanted organ.

The post Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP appeared first on Insights.

Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D.

Barbara J. Toman — Tue, 12 Nov 2024 14:00:00 +0000

John Logan Black, M.D., explains how Mayo Clinic Laboratories' UGT1A1 tests (Mayo IDs: U1A1Q and UGTFZ) identify genetic variants that increase the risk of potentially life-threatening reactions to irinotecan, a chemotherapy agent.

The post Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D. appeared first on Insights.

Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

Barbara J. Toman — Tue, 10 Sep 2024 13:00:00 +0000

Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' unique genetic tests identify patients at high risk of severe reactions to fluoropyrimidines — a type of chemotherapy drug. Test results can guide clinical decision-making for safer cancer treatment.

The post Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D. appeared first on Insights.

Focused Pharmacogenomics Panel [Test in Focus]

Samantha Rossi — Tue, 14 Sep 2021 12:45:00 +0000

Ann Moyer, M.D., Ph.D., explains Mayo Clinic Labs’ new focused pharmacogenomics panel, a real-time, PCR-based testing approach that assesses 10 genes known for their drug-gene associations, to provide guidance on medication selection for patients across a variety of specialities.

The post Focused Pharmacogenomics Panel [Test in Focus] appeared first on Insights.

Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus]

Emily Linginfelter — Thu, 01 Aug 2019 12:35:24 +0000

Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can be taken due to the results of this testing.

The post Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus] appeared first on Insights.